Wealth Science Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.06M Sell
1,777
-387
-18% -$457K 0.86% 21
2026
Q2
$2.6M Sell
2,164
-177
-8% -$181K 1.15% 17
2026
Q1
$2.52M Hold
2,341
– – 1.42% 14
2025
Q4
$2.52M Hold
2,341
– – 1.45% 14

Other funds holding LLY

Wealth Science Advisors's LLY Position: Q3 2026 in Review

Wealth Science Advisors reduced its Eli Lilly (LLY) stake by 18% in Q3 2026, selling an estimated $457K and leaving 1,777 shares worth $2.06M. The position accounts for 0.86% of the portfolio, ranked #21.

Wealth Science Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.6M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wealth Science Advisors held 1,777 shares of Eli Lilly worth $2.06M as of Q3 2026.
  • Wealth Science Advisors sold 387 Eli Lilly shares in Q3 2026, an estimated $457K.
  • Eli Lilly made up 0.86% of Wealth Science Advisors's portfolio in Q3 2026, its #21 holding.
  • Wealth Science Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Wealth Science Advisors's Eli Lilly position peaked at $2.6M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.